chr14-56580030-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017799.4(TMEM260):āc.116T>Cā(p.Val39Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000181 in 1,250,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V39E) has been classified as Uncertain significance.
Frequency
Consequence
NM_017799.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMEM260 | NM_017799.4 | c.116T>C | p.Val39Ala | missense_variant | 1/16 | ENST00000261556.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMEM260 | ENST00000261556.11 | c.116T>C | p.Val39Ala | missense_variant | 1/16 | 2 | NM_017799.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000127 AC: 3AN: 23664Hom.: 0 AF XY: 0.0000872 AC XY: 1AN XY: 11468
GnomAD4 exome AF: 0.000161 AC: 177AN: 1098268Hom.: 0 Cov.: 30 AF XY: 0.000154 AC XY: 80AN XY: 519128
GnomAD4 genome AF: 0.000322 AC: 49AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000363 AC XY: 27AN XY: 74478
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2023 | The c.116T>C (p.V39A) alteration is located in exon 1 (coding exon 1) of the TMEM260 gene. This alteration results from a T to C substitution at nucleotide position 116, causing the valine (V) at amino acid position 39 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at